New, non-surgical treatments for gallstone disease will be one of three topics presented at a meeting of the Salt Lake City chapter of the American Liver Foundation from 7:15 to 9 p.m. May 23 at the Red Lion Inn.

Dr. Kenneth N. Buchi, director of the University of Utah gastroenterology/endoscopy service, will discuss approved and experimental therapies, including the recently available oral medication Actigall for the dissolution of cholesterol gallstones.